Top Markets
Coin of the day
NuGenerex Immuno-Oncology, Inc. NuGenerex Immuno-Oncology, Inc.

NuGenerex Immuno-Oncology, Inc.

NUGX
株式のランク #41797
NuGenerex Immuno-Oncology, Inc. is an oncology firm committed to treating... NuGenerex Immuno-Oncology, Inc. is an oncology firm committed to treating cancer through the strategic modulation of the immune system. The company's development pipeline includes a range of immunotherapeutic products and vaccines. Notably, it is advancing AE37, a peptide immunotherapeutic vaccine, which is currently undergoing Phase II clinical studies for metastatic triple-negative breast cancer. Founded in 1993 and headquartered in Miramar, Florida, the entity was formerly named Antigen Express, Inc. NuGenerex Immuno-Oncology, Inc. operates as a subsidiary of Generex Biotechnology Corporation.
株価
$0.0001
最終同期: 2023-05-22
時価総額
$10.03K
変化(1日)
0.00%
変化(1年)
0.00%
US
取引 NuGenerex Immuno-Oncology, Inc. (NUGX)

カテゴリー

NuGenerex Immuno-Oncology, Inc.(NUGX)の株価履歴
終値の最高値: $0.00 (2023-05-01)

終値の最安値: $1.44 (2021-03-01)
NuGenerex Immuno-Oncology, Inc. の株価履歴(2021 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2023 75.00%
2022 -98.81%
2021 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$527.87 33.33%
US
$873.57 35.10%
NL
$736.38 7.69%
CH
$263.09 18.09%
BE
$1.07K -7.34%
KR